檢索結果 - Dong‐Wan Kim

Refine Results
  1. 1
    Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception

    Botulinum Toxin as a Pain Killer: Players and Actions in Antinociception 由 Dong-Wan Kim, Sun-Kyung Lee, Joohong Ahnn

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  2. 2
    Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients

    Elevated TGF-β1 Secretion and Down-Modulation of NKG2D Underlies Impaired NK Cytotoxicity in Cancer Patients 由 June-Chul Lee, Kyung‐Mi Lee, Dong‐Wan Kim, Dae Seog Heo

    出版 2004
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Current Concepts for Classification and Treatment of Distal Clavicle Fractures

    Current Concepts for Classification and Treatment of Distal Clavicle Fractures 由 Dong-Wan Kim, Du‐Han Kim, Beom‐Soo Kim, Chul‐Hyun Cho

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  4. 4
    Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute

    Cancer Treatment near the End-of-Life Becomes More Aggressive: Changes in Trend during 10 Years at a Single Institute 由 Younak Choi, Bhumsuk Keam, Tae Min Kim, Se‐Hoon Lee, Dong‐Wan Kim, Dae Seog Heo

    出版 2015
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer

    Generalization and representativeness of phase III immune checkpoint blockade trials in non‐small cell lung cancer 由 Shin Hye Yoo, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment

    Soluble PD-L1 is a predictive and prognostic biomarker in advanced cancer patients who receive immune checkpoint blockade treatment 由 So Yeon Oh, Soyeon Kim, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    The architecture of SARS-CoV-2 transcriptome

    The architecture of SARS-CoV-2 transcriptome 由 Dong-Wan Kim, Joo-Yeon Lee, Jeong‐Sun Yang, Jun Won Kim, V. Narry Kim, Hyeshik Chang

    出版 2020
    獲取全文
    Pré-impressão
    加到收藏夾
    Saved in:
  8. 8
    The Architecture of SARS-CoV-2 Transcriptome

    The Architecture of SARS-CoV-2 Transcriptome 由 Dong-Wan Kim, Joo-Yeon Lee, Jeong-Sun Yang, Jun Won Kim, V. Narry Kim, Hyeshik Chang

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Molecular Changes Associated with Acquired Resistance to Crizotinib in <i>ROS1</i>-Rearranged Non–Small Cell Lung Cancer

    Molecular Changes Associated with Acquired Resistance to Crizotinib in <i>ROS1</i>-Rearranged Non–Small Cell Lung Cancer 由 Ahnah Song, Tae Min Kim, Dong‐Wan Kim, Soyeon Kim, Bhumsuk Keam, Se‐Hoon Lee, Dae Seog Heo

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer

    Erlotinib Versus Gefitinib for Control of Leptomeningeal Carcinomatosis in Non–Small-Cell Lung Cancer 由 Eunyoung Lee, Bhumsuk Keam, Dong‐Wan Kim, Tae Min Kim, Se‐Hoon Lee, Doo Hyun Chung, Dae Seog Heo

    出版 2013
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib

    Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib 由 Seulki Kim, Tae Min Kim, Dong‐Wan Kim, Soyeon Kim, Miso Kim, Yong‐Oon Ahn, Bhumsuk Keam, Dae Seog Heo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Ceritinib in patients with advanced anaplastic lymphoma kinase–rearranged anaplastic large-cell lymphoma

    Ceritinib in patients with advanced anaplastic lymphoma kinase–rearranged anaplastic large-cell lymphoma 由 Heike Richly, Tae Min Kim, Martin Schüler, Dong‐Wan Kim, Simon J. Harrison, Alice T. Shaw, Anthony Boral, A. Yovine, Benjamin Solomon

    出版 2015
    獲取全文 獲取全文
    Carta
    加到收藏夾
    Saved in:
  13. 13
    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor

    Intratumoral heterogeneity characterized by pretreatment PET in non-small cell lung cancer patients predicts progression-free survival on EGFR tyrosine kinase inhibitor 由 Sehhoon Park, Seunggyun Ha, Se‐Hoon Lee, Jin Chul Paeng, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes

    Virus-Enabled Synthesis and Assembly of Nanowires for Lithium Ion Battery Electrodes 由 Ki Tae Nam, Dong‐Wan Kim, Pil J. Yoo, C.‐Y. Chiang, Nonglak Meethong, Paula T. Hammond, Yet‐Ming Chiang, Angela M. Belcher

    出版 2006
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Antibiotic use during the last days of life in cancer patients

    Antibiotic use during the last days of life in cancer patients 由 Dong Yoon Oh, J. Kim, Dong‐Wan Kim, Seock‐Ah Im, T.Y. KIM, D. S. Heo, Y-J. Bang, N.K. KIM

    出版 2006
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis

    The Effect of Induction Chemotherapy Using Docetaxel, Cisplatin, and Fluorouracil on Survival in Locally Advanced Head and Neck Squamous Cell Carcinoma: A Meta-Analysis 由 Ryul Kim, Seokyung Hahn, Junghoon Shin, Chan-Young Ock, Miso Kim, Bhumsuk Keam, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2015
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  17. 17
    Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma

    Inhibition of MEK with trametinib enhances the efficacy of anti-PD-L1 inhibitor by regulating anti-tumor immunity in head and neck squamous cell carcinoma 由 Seong-Ho Kang, Bhumsuk Keam, Yong‐Oon Ahn, Ha-Ram Park, Miso Kim, Tae Min Kim, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma

    A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma 由 Miso Kim, Tae‐Min Kim, Bhumsuk Keam, Yu Jung Kim, Jin Chul Paeng, Kyung Chul Moon, Dong‐Wan Kim, Dae Seog Heo

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced Non–Small-Cell Lung Cancer

    Patient-Reported Outcomes and Quality of Life in PROFILE 1007: A Randomized Trial of Crizotinib Compared with Chemotherapy in Previously Treated Patients with ALK-Positive Advanced... 由 Fiona Blackhall, Dong‐Wan Kim, Benjamin Besse, Hiroshi Nokihara, Ji‐Youn Han, Keith D. Wilner, Arlene Reisman, Shrividya Iyer, Vera Hirsh, Alice T. Shaw

    出版 2014
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation

    Mixed tailing by TENT4A and TENT4B shields mRNA from rapid deadenylation 由 Jaechul Lim, Dong-Wan Kim, Young-Suk Lee, Minju Ha, Mihye Lee, Jinah Yeo, Hyeshik Chang, Jaewon Song, Kwangseog Ahn, V. Narry Kim

    出版 2018
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: